B-Cell Lymphoma Cells Overexpressing BMI-1 Are Correlated with Drug Resistance through Enhanced Expression of Survivin and Are Effectively Eliminated by T Cells with Anti-CD38 Chimeric Receptor

被引：0
|
作者：
Bhattacharyya, Joyeeta [1 ]
Mihara, Keichiro [1 ]
Ohtsubo, Motoaki [2 ]
Yasunaga, Shin'ichiro [2 ]
Takihara, Yoshihiro [2 ]
Hoshi, Masaharu [3 ]
Kimura, Akiro [1 ]
机构：
[1] Hiroshima Univ, Dept Hematol & Oncol, Res Inst Radiat Biol & Med, Hiroshima, Japan
[2] Hiroshima Univ, Dept Stem Cell Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan
[3] Hiroshima Univ, Dept Radiat Biophys, Res Inst Radiat Biol & Med, Hiroshima, Japan
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1488 / 1488
页数：1
相关论文
共 50 条
  • [1] B-CELL LYMPHOMA CELLS OVEREXPRESSING BMI-1 ARE CORRELATED WITH DRUG RESISTANCE THROUGH ENHANCED EXPRESSION OF SURVIVIN AND ARE MORE EFFECTIVELY ELIMINATED BY T CELLS WITH CHIMERIC RECEPTOR AGAINST CD38 THAN CD19
    Mihara, K.
    Bhattacharyya, J.
    Ohtsubo, M.
    Takihara, Y.
    Hoshi, M.
    Kimura, A.
    ANNALS OF ONCOLOGY, 2011, 22 : 206 - 206
  • [2] OVEREXPRESSION OF BMI-1 IS CORRELATED WITH DRUG RESISTANCE IN B-CELL LYMPHOMAS THROUGH ENHANCED EXPRESSION OF SURVIVIN
    Bhattacharyya, J.
    Mihara, K.
    Ohtsubo, M.
    Yasunaga, S.
    Takihara, Y.
    Kimura, A.
    Hoshi, M.
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : S12 - S13
  • [3] Overexpression of BMI-1 correlates with drug resistance in B-cell lymphoma cells through the stabilization of survivin expression
    Bhattacharyya, Joyeeta
    Mihara, Keichiro
    Ohtsubo, Motoaki
    Yasunaga, Shin'ichiro
    Takei, Yoshifumi
    Yanagihara, Kazuyoshi
    Sakai, Akira
    Hoshi, Masaharu
    Takihara, Yoshihiro
    Kimura, Akiro
    CANCER SCIENCE, 2012, 103 (01): : 34 - 41
  • [4] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1
    Bhattacharyya, J.
    Mihara, K.
    Kitanaka, A.
    Yanagihara, K.
    Kubo, T.
    Takei, Y.
    Kimura, A.
    Takihara, Y.
    BLOOD CANCER JOURNAL, 2012, 2 : e75 - e75
  • [5] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1
    J Bhattacharyya
    K Mihara
    A Kitanaka
    K Yanagihara
    T Kubo
    Y Takei
    A Kimura
    Y Takihara
    Blood Cancer Journal, 2012, 2 : e75 - e75
  • [6] T cells bearing anti-CD19 and/or anti-CD38 chimeric antigen receptors effectively abrogate primary double-hit lymphoma cells
    Mihara, Keichiro
    Yoshida, Tetsumi
    Takei, Yoshifumi
    Sasaki, Naomi
    Takihara, Yoshihiro
    Kuroda, Junya
    Ichinohe, Tatsuo
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [7] Synergistic effect of T-cell adoptive immunotherapy with anti-CD19 or anti-CD38 chimeric receptor on B-cell lymphoma in conjunction with rituximab
    Mihara, K.
    Yanagihara, K.
    Takigahira, M.
    Takihara, Y.
    Kimura, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 159 - 159
  • [8] Synergistic and Persistent Effect of T-Cell Immunotherapy with Anti-CD19 or Anti-CD38 Chimeric Receptor on B-Cell Lymphoma in Conjunction with Rituximab
    Mihara, Keichiro
    Yanagihara, Kazuyoshi
    Takigahira, Misato
    Takihara, Yoshihiro
    Kimura, Akiro
    BLOOD, 2008, 112 (11) : 904 - 904
  • [9] T cells bearing anti-CD19 and/or anti-CD38 chimeric antigen receptors effectively abrogate primary double-hit lymphoma cells
    Keichiro Mihara
    Tetsumi Yoshida
    Yoshifumi Takei
    Naomi Sasaki
    Yoshihiro Takihara
    Junya Kuroda
    Tatsuo Ichinohe
    Journal of Hematology & Oncology, 10
  • [10] Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma
    Mihara, Keichiro
    Yanagihara, Kazuyoshi
    Takigahira, Misato
    Kitanaka, Akira
    Imai, Chihaya
    Bhattacharyya, Joyeeta
    Kubo, Takanori
    Takei, Yoshifumi
    Yasunaga, Shin'ichiro
    Takihara, Yoshihiro
    Kimura, Akiro
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (01) : 37 - 46
12345